Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Bertrand

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
British Journal of Clinical Pharmacology|May 4, 2006
Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospitalArno Muller, Dominique L Monnet, Daniel Talon, et al.
Infection Control and Hospital Epidemiology|November 19, 2008
Ecological study of the effectiveness of isolation precautions in the management of hospitalized patients colonized or infected with Acinetobacter baumanniiHoussein Gbaguidi-Haore, Sophie Legast, Michelle Thouverez, et al.
International Journal of Antimicrobial Agents|August 21, 2003
Molecular epidemiology of Enterobacteriaceae producing extended-spectrum beta-lactamase in a French university-affiliated hospitalXavier Bertrand, D Hocquet, K Boisson, et al.
Critical Care (London, England)|July 1, 2005
Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care unitsArno Muller, Daniel Talon, Alexandre Potier, et al.
International Journal of Antimicrobial Agents|September 22, 2014
Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospitalJeremy Lafolie, Marie-Hélène Nicolas-Chanoine, Frédéric Grenouillet, et al.
International Journal of Medical Microbiology : IJMM|August 16, 2014
Matrix-assisted laser desorption ionization-time of flight mass spectrometry assigns Escherichia coli to the phylogroups A, B1, B2 and DMarlène Sauget, Marie-Hélène Nicolas-Chanoine, Nadège Cabrolier, et al.
Veterinary Microbiology|January 3, 2018
mcr-1-like detection in commensal Escherichia coli and Salmonella spp. from food-producing animals at slaughter in EuropeFarid El Garch, Anno de Jong, Xavier Bertrand, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in FranceDidier Hocquet, Patrick Plésiat, Barbara Dehecq, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French CommunityAnaïs Potron, Didier Hocquet, Pauline Triponney, et al.
Microbial Genomics|November 28, 2017
Genomic characterization of a local epidemic <i>Pseudomonas aeruginosa</i> reveals specific features of the widespread clone ST395Marie Petitjean, Daniel Martak, Alicia Silvant, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
British Journal of Clinical Pharmacology|May 4, 2006
Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospitalArno Muller, Dominique L Monnet, Daniel Talon, et al.
Infection Control and Hospital Epidemiology|November 19, 2008
Ecological study of the effectiveness of isolation precautions in the management of hospitalized patients colonized or infected with Acinetobacter baumanniiHoussein Gbaguidi-Haore, Sophie Legast, Michelle Thouverez, et al.
International Journal of Antimicrobial Agents|August 21, 2003
Molecular epidemiology of Enterobacteriaceae producing extended-spectrum beta-lactamase in a French university-affiliated hospitalXavier Bertrand, D Hocquet, K Boisson, et al.
Critical Care (London, England)|July 1, 2005
Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care unitsArno Muller, Daniel Talon, Alexandre Potier, et al.
International Journal of Antimicrobial Agents|September 22, 2014
Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospitalJeremy Lafolie, Marie-Hélène Nicolas-Chanoine, Frédéric Grenouillet, et al.
International Journal of Medical Microbiology : IJMM|August 16, 2014
Matrix-assisted laser desorption ionization-time of flight mass spectrometry assigns Escherichia coli to the phylogroups A, B1, B2 and DMarlène Sauget, Marie-Hélène Nicolas-Chanoine, Nadège Cabrolier, et al.
Veterinary Microbiology|January 3, 2018
mcr-1-like detection in commensal Escherichia coli and Salmonella spp. from food-producing animals at slaughter in EuropeFarid El Garch, Anno de Jong, Xavier Bertrand, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in FranceDidier Hocquet, Patrick Plésiat, Barbara Dehecq, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French CommunityAnaïs Potron, Didier Hocquet, Pauline Triponney, et al.
Microbial Genomics|November 28, 2017
Genomic characterization of a local epidemic <i>Pseudomonas aeruginosa</i> reveals specific features of the widespread clone ST395Marie Petitjean, Daniel Martak, Alicia Silvant, et al.
Pageof 15